{"id":"NCT01429051","sponsor":"Takeda","briefTitle":"A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain","officialTitle":"A Dose Titrated Clinical Trial With a Placebo-controlled, Double-blind, Randomised, Cross-over Phase to Demonstrate the Efficacy of 400 μg Intranasal Fentanyl (INFS) Dose Strength, and to Evaluate 12 Weeks Safety and Nasal Tolerability of All Dose Strengths Between 50 μg and 400 μg, in Cancer Patients With Breakthrough Pain.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2011-09-05","resultsPosted":"2014-03-26","lastUpdate":"2014-03-26"},"enrollment":46,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Break Through Pain","Cancer"],"interventions":[{"type":"DRUG","name":"Intranasal Fentanyl Spray (INFS)","otherNames":["Instanyl®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Intranasal Fentanyl Spray (INFS)","type":"EXPERIMENTAL"}],"summary":"The aim of this clinical trial was to demonstrate the efficacy of a 400 μg dose strength of intranasal fentanyl spray (INFS, Instanyl®) and to evaluate the safety and to establish long term tolerability of treatment with INFS doses of 50, 100, 200 and 400 μg.","primaryOutcome":{"measure":"Induction Phase: Pain Intensity Difference at 10 Minutes (PID10) After Treatment","timeFrame":"During the efficacy phase (II), at each episode of breakthrough pain, at 0 and 10 minutes after first dose of study drug.","effectByArm":[{"arm":"Intranasal Fentanyl Spray (INFS)","deltaMin":2.5,"sd":null},{"arm":"Placebo","deltaMin":1.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":11,"countries":["Hungary","Norway","Russia"]},"refs":{"pmids":["25641199"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":45},"commonTop":["Nausea","Dizziness","Vomiting","Fatigue","Abdominal pain upper"]}}